[Low-threshold primary care for patients in opiate maintenance therapy. A pilot project in Malmö, Sweden, integrates primary care and OMT]. / Egen primärvård för patienter med substitutionsbehandling - Vårdcentral och LARO-mottagningar i Malmö driver pilotprojekt.

Low-threshold primary care for patients in opiate maintenance therapy. A pilot project in Malmö, Sweden, integrates primary care and OMT  This report illustrates how integration of primary care and opiate maintenance therapy (OMT) may improve OMT patients health and minimize obstacles for care seeking. OMT patients have poor health. Around 80 % have hepatitis C, a majority smoke tobacco, and socio-economic status is generally low. However, somatic health is often under-prioritized in this group. To improve OMT patients physical health', two OMT clinics and one primary care center in Malmö, Sweden, started a pilot project in 2014. This project includes: OMT personnel suggest their patients to see a primary care physician and assist with booking; Primary care physicians interested in and/or experienced from addiction care; Closer contact between primary care and OMT, regarding initiated medication, recommended follow-up, referrals, etc. Patients and care givers stress the importance of easily accessible care for this vulnerable patient group. To scientifically evaluate such projects, controlled studies are necessary.

IGRT induced dose burden for a variety of imaging protocols at two different anatomical sites.

BACKGROUND AND PURPOSE: Increase in positioning accuracy and treatment adaptation is supported by image guidance. The downside is the concomitant imaging dose. In this study, we report on the total dose picture for different styles of image guidance. MATERIALS AND METHODS: Dose was measured in the Alderson phantom using TLD's. IGRT technology investigated included CBCT at the linac and simulator, multislice-CT and kV and MV planar imaging. Clinically used imaging protocols were applied and the total dose picture was assessed for four different sequences of imaging for a prostate and a head and neck treatment. RESULTS: The different imaging geometries for the various imaging modalities resulted in fairly different dose distributions. Head and neck doses up to 100 mGy and higher were found for portal imaging and multislice-CT. Depending on the IGRT sequence used maximum total dose varies between 120 and 1500 mGy. In prostate maximum doses between 40 and 100 mGy were found for portal imaging and CBCT at the linac. Here the maximum total dose varies between 120 and 2250 mGy depending on the sequence used. DISCUSSION: Factors like patient dimensions, age and sex can influence the applicability of presented values. Careful consideration of imaging dose especially for very intense imaging sequences is recommended.

Superficial dose distribution in breast for tangential radiation treatment, Monte Carlo evaluation of Eclipse algorithms in case of phantom and patient geometries.

PURPOSE: The aim of this study is to examine experimentally and by the Monte Carlo method the accuracy of the Eclipse Pencil Beam Convolution (PBC) and Analytical Anisotropic Algorithm (AAA) algorithms in the superficial region (0-2 cm) of the breast for tangential photon beams in a phantom case as well as in a number of patient geometries. The aim is also to identify differences in how the patient computer tomography data are handled by the treatment planning system and in the Monte Carlo simulations in order to reduce influences of these effects on the evaluation. MATERIALS AND METHODS: Measurements by thermoluminescent dosimeters and gafchromic film are performed for six MV tangential irradiation of the cylindrical solid water phantom. Tangential treatment of seven patients is investigated considering open beams. Dose distributions are obtained by the Eclipse PBC and AAA algorithms. Monte Carlo calculations are carried out by BEAMnrc/DOSXYZnrc code package. Calculations are performed with a calculation grid of 1.25×1.25×5 mm(3) for PBC and 2×2×5 mm(3) for AAA and Monte Carlo, respectively. Dose comparison is performed in both dose and spatial domains by the normalized dose difference method. RESULTS: Experimental profiles from the surface toward the geometrical center of the cylindrical phantom are obtained at the beam entrance and exit as well as laterally. Full dose is received beyond 2 mm in the lateral superficial region and beyond 7 mm at the beam entrance. Good agreement between experimental, Monte Carlo and AAA data is obtained, whereas PBC is seen to underestimate the entrance dose the first 3-4 mm and the lateral dose by more than 5% up to 8 mm depth. In the patient cases considered, AAA and Monte Carlo show agreement within 3% dose and 4 mm spatial tolerance. PBC systematically underestimates the dose at the breast apex. The dimensions of region out of tolerance vary with the local breast shape. Different interpretations of patient boundaries in Monte Carlo and the Eclipse are found to influence the evaluation. Computer tomography marker wire may introduce local disturbance effects on the comparison as well. These factors are not related to the accuracy of the calculation algorithms and their effect is taken into account in the evaluation. CONCLUSIONS: The accuracy of AAA in the case of the solid water phantom is comparable with that of the Monte Carlo method. The AAA-Monte Carlo differences in the patient cases considered are within 3%, 4 mm tolerance. The PBC algorithm does not give equivalent results. In the phantom case, PBC underestimates the lateral dose by more than 5% up to 8 mm depth. The PBC-Monte Carlo differences in the patient cases are outside the tolerance at the breast apex. The dimension of region varies with the breast shape being typically 8-10 mm long and 6-8 mm deep.

Pain and mean absorbed dose to the pubic bone after radiotherapy among gynecological cancer survivors.

PURPOSE: To analyze the relationship between mean absorbed dose to the pubic bone after pelvic radiotherapy for gynecological cancer and occurrence of pubic bone pain among long-term survivors. METHODS AND MATERIALS: In an unselected, population-based study, we identified 823 long-term gynecological cancer survivors treated with pelvic radiotherapy during 1991-2003. For comparison, we used a non-radiation-treated control population of 478 matched women from the Swedish Population Register. Pain, intensity of pain, and functional impairment due to pain in the pubic bone were assessed with a study-specific postal questionnaire. RESULTS: We analyzed data from 650 survivors (participation rate 79%) with median follow-up of 6.3 years (range, 2.3-15.0 years) along with 344 control women (participation rate, 72 %). Ten percent of the survivors were treated with radiotherapy; ninety percent with surgery plus radiotherapy. Brachytherapy was added in 81%. Complete treatment records were recovered for 538/650 survivors, with dose distribution data including dose-volume histograms over the pubic bone. Pubic bone pain was reported by 73 survivors (11%); 59/517 (11%) had been exposed to mean absorbed external beam doses <52.5 Gy to the pubic bone and 5/12 (42%) to mean absorbed external beam doses ≥ 52.5 Gy. Thirty-three survivors reported pain affecting sleep, a 13-fold increased prevalence compared with control women. Forty-nine survivors reported functional impairment measured as pain walking indoors, a 10-fold increased prevalence. CONCLUSIONS: Mean absorbed external beam dose above 52.5 Gy to the pubic bone increases the occurrence of pain in the pubic bone and may affect daily life of long-term survivors treated with radiotherapy for gynecological cancer.

Absorbed dose and dose rate using the Varian OBI 1.3 and 1.4 CBCT system.

According to published data, the absorbed dose used for a CBCT image acquisition with Varian OBI v1.3 can be as high as 100 mGy. In 2008 Varian released a new OBI version (v1.4), which promised to reduce the imaging dose. In this study, absorbed doses used for CBCT image acquisitions with the default irradiation techniques of Varian OBI v1.3 and v1.4 are measured. TLDs are used to derive dose distributions at three planes inside an anthropomorphic phantom. In addition, point doses and dose profiles inside a 'stack' of three CTDI body phantoms are measured using a new solid state detector, the CT Dose Profiler. With the CT Dose Profiler, the individual pulses from the X-ray tube are also studied. To verify the absorbed dose measured with the CT Dose Profiler, it is compared to TLD. The image quality is evaluated using a Catphan phantom. For OBI v1.3, doses measured in transverse planes of the Alderson phantom range between 64 mGy and 144 mGy. The average dose is around 100 mGy. For OBI v1.4, doses measured in transverse planes of the Alderson phantom range between 1 mGy and 51 mGy. Mean doses range between 3-35 mGy depending on CBCT mode. CT Dose Profiler data agree with TLD measurements in a CTDI phantom within the uncertainty of the TLD measurements (estimated SD +/- 10%). Instantaneous dose rate at the periphery of the phantom can be higher than 20 mGy/s, which is 10 times the dose rate at the center. The spatial resolution in v1.4 is not as high as in v1.3. In conclusion, measurements show that the imaging doses for default modes in Varian OBI v1.4 CBCT system are significantly lower than in v1.3. The CT Dose Profiler is proven fast and accurate for CBCT applications.

A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.

The use of untraditional treatment modalities for external beam radiotherapy such as intensity modulated radiation therapy (IMRT) and proton beam therapy is increasing. This review focuses on the changes in the dose distribution and the impact on radiation related risks for long-term cancer survivors. We compare conventional radiotherapy, IMRT, and proton beam therapy based on published treatment planning studies as well as published measurements and Monte Carlo simulations of out-of-field dose distributions. Physical dose parameters describing the dose distribution in the target volume, the conformity index, the dose distribution in organs at risk, and the dose distribution in non-target tissue, respectively, are extracted from the treatment planning studies. Measured out-of-field dose distributions are presented as the dose equivalent as a function of distance from the treatment field. Data in the literature clearly shows that, compared with conventional radiotherapy, IMRT improves the dose distribution in the target volume, which may increase the probability of tumor control. IMRT also seems to increase the out-of-field dose distribution, as well as the irradiated non-target volume, although the data is not consistent, leading to a potentially increased risk of radiation induced secondary malignancies, while decreasing the dose to normal tissues close to the target volume, reducing the normal tissue complication probability. Protons show no or only minor advantage on the dose distribution in the target volume and the conformity index compared to IMRT. However, the data consistently shows that proton beam therapy substantially decreases the OAR average dose compared to the other two techniques. It is also clear that protons provide an improved dose distribution in non-target tissues compared to conventional radiotherapy and IMRT. IMRT and proton beam therapy may significantly improve tumor control for cancer patients and quality of life for long-term cancer survivors.

Pencil beam approach for correcting the energy dependence artifact in film dosimetry for IMRT verification.

The higher sensitivity to low-energy scattered photons of radiographic film compared to water can lead to significant dosimetric error when the beam quality varies significantly within a field. Correcting for this artifact will provide greater accuracy for intensity modulated radiation therapy (IMRT) verification dosimetry. A procedure is developed for correction of the film energy-dependent response by creating a pencil beam kernel within our treatment planning system to model the film response specifically. Film kernels are obtained from EGSnrc Monte Carlo simulations of the dose distribution from a 1 mm diameter narrow beam in a model of the film placed at six depths from 1.5 to 40 cm in polystyrene and solid water phantoms. Kernels for different area phantoms (50 x 50 cm2 and 25 x 25 cm2 polystyrene and 30 x 30 cm2 solid water) are produced. The Monte Carlo calculated kernel is experimentally verified with film, ion chamber and thermoluminescent dosimetry (TLD) measurements in polystyrene irradiated by a narrow beam. The kernel is then used in convolution calculations to, predict the film response in open and IMRT fields. A 6 MV photon beam and Kodak XV2 film in a polystyrene phantom are selected to test the method as they are often used in practice and can result in large energy-dependent artifacts. The difference in dose distributions calculated with the film kernel and the water kernel is subtracted from film measurements to obtain a practically film artifact free IMRT dose distribution for the Kodak XV2 film. For the points with dose exceeding 5 cGy (11% of the peak dose) in a large modulated field and a film measurement inside a large polystyrene phantom at depth of 10 cm, the correction reduces the fraction of pixels for which the film dose deviates from dose to water by more than 5% of the mean film dose from 44% to 6%.

Influence of phantom material and phantom size on radiographic film response in therapy photon beams.

The energy dependence of radiographic film can introduce dosimetric errors when evaluating photon beams. The variation of the film response, which is attributed to the changing photon spectrum with depth and field size, has been the subject of numerous publications in recent years. However, these data show large unexplained differences in the magnitude of this variation among independent studies. To try to resolve this inconsistency, this study assesses the dependence of radiographic film response on phantom material and phantom size using film measurements and Monte Carlo calculations. The relative dose measured with film exposed to 6 MV x rays in various phantoms (polystyrene, acrylic, Solid Water, and water; the lateral phantom dimensions vary from 25 to 50 cm square; backscatter thickness varies from 10 to 30 cm) is compared with ion chamber measurements in water. Ranges of field size (5 x 5 to 40 x 40 cm2) and depth (dmax to 20 cm) are studied. For similar phantom and beam configurations, Monte Carlo techniques generate photon fluence spectra from which the relative film response is known from an earlier study. Results from film response measurements agree with those derived from Monte Carlo calculations within 3%. For small fields (< or = 10 x 10 cm2) and shallow depths (< or = 10 cm) the film response variation is small, less than 4%, for all phantoms. However, for larger field sizes and depths, the phantom material and phantom size have a greater influence on the magnitude of the film response. The variation of film response, over the ranges of field sizes and depths studied, is 50% in polystyrene compared with 30% in water. Film responses in Solid Water and water phantoms are similar; acrylic is between water and polystyrene. In polystyrene the variation of film response for a 50 cm square phantom is nearly twice that observed in a 25 cm square phantom. This study shows that differences in the configuration of the phantoms used for film dosimetry can explain much of the inconsistency for film response reported in the literature.

Predicting energy response of radiographic film in a 6 MV x-ray beam using Monte Carlo calculated fluence spectra and absorbed dose.

The advantage of radiographic film is that it allows two-dimensional, high-resolution dose measurement. While there is concern over its photon energy dependence, these problems are considered acceptable within small fields, where the scatter component is small. The application of film dosimetry to intensity modulated radiotherapy (IMRT) raises additional concern since the primary fluence may vary significantly within the field. The varying primary fluence in combination with a large scatter fraction, present for large fields and large depths, causes the spectrum at various points within the IMRT field to differ from the spectrum in the uniform fields typically used for calibrating the film. As a result, significant artifacts are introduced in the measured dose distribution. The purpose of this work is to quantify and develop a method to correct for these artifacts. Two approaches based on Monte Carlo (MC) simulations are examined. In the first method, the film artifact, as quantified by film and ion chamber output measurements in uniform square fields, is derived from the MC calculated ratio of absorbed doses to film and to water. In the second method, the measured film artifact is correlated with MC calculated photon spectra, revealing a strong correlation between the measured artifact and the "scatter"-to-"primary" ratio, defined by the ratio of the number of photons below to the number of photons above 0.1 MeV, independent of field size and depth. These methods are evaluated in high- and low-dose regions of a large intensity-modulated field created with a central block. The spectral approach is also tested with a clinical IMRT field. The absorbed dose method accurately corrects the measured film dose in the open part of the field and in points under the block and outside the field. The dose error is reduced from as much as 16% of the open field dose to less than 1%, as verified with an ion chamber. The spectral method accurately corrects the measured film dose in the open region of the centrally blocked field, but does not fully correct for the film artifact for points under the block and outside the field, where the spectrum is substantially different. Applied to the clinical field, the corrected film measurement shows good agreement with data obtained with a two-dimensional diode array.

Performance analysis and determination of the p(wall) correction factor for 60Co gamma-ray beams for Wellhöfer Roos-type plane-parallel chambers.

The wall perturbation correction factor p(wall) in 60Co for Wellhöfer Roos-type plane-parallel ionization chambers is determined experimentally and compared with the results of a previous study using PTW-Roos chambers (Palm et al 2000 Phys. Med. Biol. 45 971-81). Five ionization chambers of the type Wellhöfer PPC-35 (or its equivalent PPC-40) are used for the analysis. Wall perturbation correction factors are obtained by assuming N(D,air) chamber factors determined by cross-calibration in a high-energy electron and in a 60Co gamma-ray beam to be equal, and by assigning any differences to the wall perturbation factor. The procedure yields a p(wall) value of 1.018 (u(c) = 0.010), which is slightly higher than the value 1.014 (u(c) = 0.010) formerly obtained for the PTW-Roos chambers using the N(D,air) method. The chamber-to-chamber variation in p(wall) for the Wellhöfer-Roos chambers is found to be very small, with a maximum difference of 0.3%. The effect of using new p(cav) values for graphite-walled Farmer-type chambers used in water in electron beams is to decrease p(wall) by approximately 0.5%. The long- and short-term stability of the Roos-type chambers manufactured by Wellhöfer is investigated by measurements at the IAEA Dosimetry Laboratory in Vienna, Austria, and at the Sahlgrenska University Hospital in Göteborg, Sweden. Calibrations made at the IAEA over several months show variations in the N(D,w) calibration factors larger than expected. based on previous experiences with PTW-Roos chambers. Measurements of the short-term stability of the Wellhöfer-Roos chambers show a marked increase in chamber response for the time the chambers are immersed in water, pointing to a possible problem in the chamber design. As a consequence of these findings, Wellhöfer is currently working on a re-design of the chamber to solve the stability problem.

Experimental determination of beam quality conversion factors k(Q) in clinical photon beams using ferrous sulphate (Fricke) dosimetry.

The implementation of protocols based on absorbed dose to water standards requires beam quality conversion factors, k(Q). Calculated values of k(Q) are available for ionization chambers used for reference dosimetry. Ideally, k(Q) should be experimentally determined at the same beam qualities as that of the user. In this work we measure k(Q) factors in clinical photon beams and compare them with calculated and measured values. Beam quality conversion factors are determined for clinical photon beams of nominal energies 4 MV, 6 MV, 15 MV, and 25 MV, for commonly used cylindrical ionization chambers. Twelve chambers of eight different types are used. For three of them, no experimental data have previously been available. The experimental procedure is based on measurements with ionization chambers and Fricke dosimetry in the reference beam (60Co gamma radiation) and in clinical linear accelerator beams. The k(Q) values determined in this work generally agree within 0.5% with previously reported experimental values both when %dd(10)x and TPR2010 are used for beam quality specification. The agreement with calculated data is generally within 0.5%, except for the 15 MV beam. For this beam the measured values are usually between 0.5% and 1% lower than the data taken from the TG-51 protocol or the TRS-398 code of practice. For three NE2571 chambers and three NE2581 chambers, the maximum observed deviation of individual k(Q) values is 0.2% and 0.4%, respectively.